Quality by Design Symposium

Pharmaceutical Quality by Design

Medicines Manufacture: The Road Map to Innovation

The Venue at the De Montfort University
Wednesday 21st March 2018

The Leicester School of Pharmacy in collaboration with ISPE UK Affiliate

The Leicester School of Pharmacy is one of the UK’s most established pharmacy schools, with more than 100 years of teaching experience; renowned for academic expertise, professional development training and world-leading research.

The Programme

We are delighted to be announce the sixth Quality by Design Symposium on 21st March 2018. This event is planned to bring together academics, regulators and industrial experts to share latest academic research aligned to the QbD agenda as well as progress in ‘real-life’ QbD implementation. The Symposium will focus on “Medicines Manufacture: Road to innovation”.

Confirmed Speakers

  • Ian McCubbin – Independent Pharma Specialist at Keirbridge Ltd (Keynote)
  • Walkiria Schlindwein – Leicester School of Pharmacy, DMU
  • Antony D’Emanuele – Head of Leicester School of Pharmacy, DMU
  • Alastair Coupe – Senior Director, Pfizer
  • Carolyn Gordon – Regulatory CMC, AstraZeneca
  • Kendal Pitt – Senior Technical Director, GlaxoSmithKline 
  • Colm Reddington – Assessor, MHRA
  • Bruce Davis – Director, Global Consulting
  • Timo Gehring – Head of Production, Peptido GmbH
  • William Holt – R&D Senior Associate – HME, Reckitt Benckiser
  • Jordan Dickens – Senior Formulation Scientist, Quotient Clinical
  • David Rudd –  former GlaxoSmithKline
  • Gordon Muirhead – GMPharma Limited
  • Mingzhong Li – Reader in Pharmaceutical Science, De Montfort University

For more information please visit the QbD Symposium Website

The Asia Pacific region (APAC), like any large territory, encompasses a blend of well-established and early-stage economies, diverse healthcare systems, and differences in language, culture, politics, and technology adoption. APAC’s size and complexity has created...